Discover how we enable you to deliver significantly higher value at much lower cost using fewer resources than any other approach

Monitoring the method’s performance during routine use to ensure it doesn't drift over time. Accessing the Report Safely

The report is designed to help laboratory managers, quality control (QC) professionals, and regulatory affairs specialists navigate the complexities of ensuring that a test method consistently produces accurate and reproducible results. Key Components of Method Validation in TR 13

Modern iterations of PDA TR 13 emphasize that validation is not a one-time "checkbox" event. It follows a : Design: Developing a method that is inherently robust. Qualification: The formal validation experiments.

While many validation guides exist, the PDA’s version is uniquely tailored to the . Sterile products often have complex formulations and require highly sensitive testing to ensure patient safety. TR 13 provides the specific technical depth needed to handle these challenges, especially when integrating modern technology like Rapid Microbiological Methods (RMM) or advanced chromatography. The Lifecycle Approach to Validation

Because PDA reports are updated to reflect the latest science and regulatory shifts, using a bootleg or outdated "free PDF" can be a compliance risk. Using an obsolete version of TR 13 during an audit could lead to observations or warning letters.

How close the test results are to the "true" value.

TR 13 outlines how to demonstrate that a method’s response is directly proportional to the concentration of the analyte within a specific range. 4. Detection Limit (LOD) and Quantitation Limit (LOQ)